Quick Answer
PROKIDNEY CORP. reported Total Assets of $335.57 million for the year ending 2025.
- PROKIDNEY CORP. showed a decrease of -23.9% in Total Assets from 2024 to 2025.
- This data is from PROKIDNEY CORP.'s annual report (Form 10-K), filed with the SEC on March 18, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2021: $622.8 thousand | Q3 2021: $251.44 million | Q1 2022: $250.75 million | Q2 2022: $251.00 million | Q3 2022: $532.44 million | Q1 2023: $495.15 million | Q2 2023: $484.22 million | Q3 2023: $451.81 million | Q1 2024: $387.76 million | Q2 2024: $499.16 million | Q3 2024: $474.79 million | Q1 2025: $406.06 million | Q2 2025: $372.13 million | Q3 2025: $351.61 million.
- Over the full 5 years of available data (2021 to 2025), PROKIDNEY CORP.'s Total Assets has grown by 732.7%.
- Historical annual values: Fiscal year 2025: $335.57 million | Fiscal year 2024: $441.07 million | Fiscal year 2023: $420.55 million | Fiscal year 2022: $518.00 million | Fiscal year 2021: $40.30 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: